Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (150) Arrow Down
Filter Results: (150) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (242)
    • People  (2)
    • News  (74)
    • Research  (150)
    • Multimedia  (1)
  • Faculty Publications  (57)

Show Results For

  • All HBS Web  (242)
    • People  (2)
    • News  (74)
    • Research  (150)
    • Multimedia  (1)
  • Faculty Publications  (57)
← Page 5 of 150 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 29 May 2001
  • Research & Ideas

Genomics: Can We Start Making Money Now?

new drugs and therapies that can be tailored to individuals and result in fewer side effects. Advances in treatments of cancer and infectious diseases are likely to be early benefits of work in genomics, Lechleiter said. Another potential... View Details
Keywords: by Sean Silverthorne
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily in the United States and in an increasingly competitive Asia.... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 10 Sep 2008
  • Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
Keywords: by John Quelch; Entertainment & Recreation; Pharmaceutical
  • 15 Jan 2018
  • Research & Ideas

A Better Business Model for Fighting Cancer

benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In an adaptive platform trial, for example, different View Details
Keywords: by Julia Hanna; Health; Pharmaceutical
  • 01 Aug 2017
  • First Look

First Look at New Research and Ideas, August 1

I find robust evidence of a negative (positive) relation between unexplained (explained) pay disparity and future firm performance. Additional tests show that the negative relation between unexplained disparity and firm performance is... View Details
Keywords: Sean Silverthorne
  • 23 Mar 2003
  • Research & Ideas

AIDS in Africa—What’s the Solution?

5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
  • 10 Oct 2017
  • First Look

First Look at New Research and Ideas, October 10, 2017

in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients,... View Details
Keywords: Sean Silverthorne
  • 24 Mar 2020
  • Research & Ideas

These Coronavirus Heroes Show Us How Crisis Leadership Works

Schinecker, CEO of Roche Diagnostics, leads a company that received the FDA’s first emergency use authorization  for a commercially developed COVID-19 test on March 13. Roche now believes it can ship up to 400,000 View Details
Keywords: by Bill George; Health
  • 23 Mar 2010
  • First Look

First Look: March 23

Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
  • 16 Oct 2013
  • Op-Ed

Response to Readers: Combating Climate Change with Nuclear Power and Fracking

With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
Keywords: by Joe Lassiter; Energy; Utilities
  • 12 Feb 2019
  • First Look

New Research and Ideas, February 12, 2019

Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
  • 27 Feb 2018
  • First Look

First Look at New Research and Ideas, February 27, 2018

prevention-focused questions. We demonstrate that every additional prevention-focused question significantly hinders the entrepreneur's ability to raise capital, fully mediating gender's effect on funding. By experimentally testing an... View Details
Keywords: Sean Silverthorne
  • 08 Jan 2008
  • First Look

First Look: January 8, 2008

Abstract We use oil price fluctuations to construct a new instrument to test the impact of transfers from wealthy OPEC nations to their poorer Muslim allies. The instrument identifies plausibly exogenous variation in foreign aid. We... View Details
Keywords: Martha Lagace
  • 31 May 2016
  • First Look

May 31, 2016

have a higher probability of walking by the clinic for reasons other than vaccination. Method: We obtained data from an employer with a free workplace influenza vaccination clinic. Using each employee’s building entry/exit swipe card data, we View Details
Keywords: Sean Silverthorne
  • 15 Jun 2016
  • Research & Ideas

These VC Partners May Make Your Firm Less Innovative

of students, the researchers surmised it may dampen innovation among competitive companies. To test that hypothesis, McDonald, Pahnke, Hallen and Wang looked at close to 200 medical device startups that developed products for minimally... View Details
Keywords: by Michael Blanding; Financial Services; Banking
  • 18 Apr 2019
  • Research & Ideas

Open Innovation Contestants Build AI-Based Cancer Tool

for Google, etc. AI is already being used as an adjunct to diagnosis in some settings. However, the bar for US Food & Drug Administration approval for a diagnostic test is appropriately high, and... View Details
Keywords: by Martha Lagace; Health; Medical Devices & Supplies
  • 19 Sep 2017
  • First Look

First Look at New Research and Ideas, September 19

Based on the fact that stores prioritize carrying products for which local demand is high, we test the hypothesis that introducing the STS functionality increased the retailer’s overall sales dispersion. We find that, on average, the... View Details
Keywords: Sean Silverthorne
  • 08 Jun 2010
  • First Look

First Look: June 8

results translate to specific predictions on how the change in homogeneity will affect firm behavior. This paper's predictions can also serve more generally as a test for the theory of culture as shared beliefs. Download this paper: View Details
Keywords: Martha Lagace
  • 07 Aug 2006
  • Research & Ideas

Whatever Happened to Caveat Emptor?

basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the focus of aggressive consumer... View Details
Keywords: by Sean Silverthorne; Retail
  • 23 May 2017
  • First Look

First Look at New Ideas and Research: May 23, 2017

about the causes of regional variations in health care expenditures. We use vignettes from patient and physician surveys linked to fee-for-service Medicare expenditures to test whether patient demand-side factors or physician supply-side... View Details
Keywords: Carmen Nobel
  • ←
  • 5
  • 6
  • 7
  • 8
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.